Delivery Order SPE2DB20D3103-SPE2DB23FP8T9

Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,609.81 firm fixed-price delivery order is for the drug Quillivant XR 25 mg/5 ml suspension, with a period of performance through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,444.41 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a specialty medication. The contract has an ultimate completion date of November 28, 2022 and was awarded on November 25, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,128.16 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles, with a completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,150.76 Firm Fixed Price Delivery Order covers the supply of Quillivant XR 25 mg/5 ml suspension medication with a completion date of November 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,270.30 delivery order contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a specialty medication. The contract has a firm fixed price and an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,280.46 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,982.09 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 mL suspension, a specialty medication. This contract is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the efficient procurement of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,579.48 Firm Fixed Price Delivery Order is for the supply of Quillivant XR, a 25 mg/5 ml suspension medication, with a period of performance through July 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,508.50 delivery order is for Quillivant XR, a 25 mg/5 ml suspension medication, with a completion date of June 24, 2022. The contract is a firm fixed-price arrangement and was not subject to any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,429.81 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a 60 ml medication. The contract has an ultimate completion date of November 1, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP8T9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,409.08 firm fixed-price delivery order is for the drug Quillivant XR 25 mg/5 ml suspension, with a completion date of September 27, 2023.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:50 AM